Letong Chemical Co.,LTD (SHE:002319)
China · Delayed Price · Currency is CNY 8.72
+0.32 (3.81%)
Nov 3, 2026, 9:25 AM CST
Letong Chemical Co.,LTD Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Revenue | 450.51 | 403.18 | 395.19 | 380.3 | 398.9 | 383.05 |
Other Revenue | 2.84 | 2.84 | 3.25 | 6.27 | 4.56 | 4.69 |
| 453.35 | 406.02 | 398.44 | 386.58 | 403.46 | 387.74 | |
Revenue Growth | 13.96% | 1.90% | 3.07% | -4.18% | 4.05% | 23.26% |
Cost of Revenue | 365.81 | 325.49 | 327.35 | 295.62 | 334.46 | 328.3 |
Gross Profit | 87.53 | 80.53 | 71.09 | 90.96 | 69 | 59.44 |
Selling, General & Admin | 54.01 | 54.16 | 56.01 | 51.69 | 57.97 | 61.73 |
Research & Development | 15.27 | 16.2 | 17.62 | 19.65 | 17.26 | 9.87 |
Other Operating Expenses | 2.69 | 4.72 | 4.72 | 4.09 | 5.05 | 4.31 |
Operating Expenses | 72.62 | 75.41 | 78.9 | 72.23 | 81.77 | 75.82 |
Operating Income | 14.92 | 5.12 | -7.81 | 18.72 | -12.77 | -16.38 |
Interest Expense | -2.71 | -10.62 | -14.03 | -14.85 | -16.13 | -16.06 |
Interest & Investment Income | 0.02 | 0.05 | 0.04 | 0.09 | 0.06 | 0.09 |
Currency Exchange Gain (Loss) | -0.08 | -0.08 | -0.21 | -0.08 | 0 | 0.26 |
Other Non Operating Income (Expenses) | -8.34 | -0.04 | -0.07 | -0.24 | -0.25 | -0.65 |
EBT Excluding Unusual Items | 3.81 | -5.57 | -22.08 | 3.64 | -29.08 | -32.74 |
Gain (Loss) on Sale of Investments | -5.84 | -5.94 | -3.37 | -0.75 | -0.1 | -0.09 |
Gain (Loss) on Sale of Assets | 0.15 | -0.03 | 0 | -0 | - | -0.03 |
Asset Writedown | -1.05 | -0.35 | - | -0.11 | -0.38 | -0.04 |
Other Unusual Items | 0.58 | 0.61 | 0.88 | 0.91 | 0.1 | 1.12 |
Pretax Income | -2.34 | -11.28 | -24.57 | 3.68 | -29.45 | -31.79 |
Income Tax Expense | 0.07 | 0.05 | 0.05 | 0.05 | 1.98 | 5.36 |
Earnings From Continuing Operations | -2.41 | -11.33 | -24.62 | 3.63 | -31.43 | -37.15 |
Minority Interest in Earnings | 0.27 | 1.3 | - | - | - | - |
Net Income | -2.14 | -10.03 | -24.62 | 3.63 | -31.43 | -37.15 |
Net Income to Common | -2.14 | -10.03 | -24.62 | 3.63 | -31.43 | -37.15 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 217 | 201 | 205 | 182 | 196 | 196 |
Shares Outstanding (Diluted) | 217 | 201 | 205 | 182 | 196 | 196 |
Shares Change | 3.79% | -2.19% | 12.93% | -7.51% | 0.47% | 6.98% |
EPS (Basic) | -0.01 | -0.05 | -0.12 | 0.02 | -0.16 | -0.19 |
EPS (Diluted) | -0.01 | -0.05 | -0.12 | 0.02 | -0.16 | -0.19 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 3.35 | 17.41 | 17.57 | 24.98 | 8.86 | 9.65 |
Free Cash Flow Per Share | 0.01 | 0.09 | 0.09 | 0.14 | 0.04 | 0.05 |
Gross Margin | 19.31% | 19.83% | 17.84% | 23.53% | 17.10% | 15.33% |
Operating Margin | 3.29% | 1.26% | -1.96% | 4.84% | -3.17% | -4.22% |
Profit Margin | -0.47% | -2.47% | -6.18% | 0.94% | -7.79% | -9.58% |
Free Cash Flow Margin | 0.74% | 4.29% | 4.41% | 6.46% | 2.20% | 2.49% |
EBITDA | 28.16 | 20.96 | 11.5 | 41.58 | 11.5 | 7.05 |
EBITDA Margin | 6.21% | 5.16% | 2.89% | 10.76% | 2.85% | 1.82% |
D&A For EBITDA | 13.24 | 15.84 | 19.31 | 22.85 | 24.27 | 23.43 |
EBIT | 14.92 | 5.12 | -7.81 | 18.72 | -12.77 | -16.38 |
EBIT Margin | 3.29% | 1.26% | -1.96% | 4.84% | -3.17% | -4.22% |
Effective Tax Rate | - | - | - | 1.26% | - | - |
Revenue as Reported | 90.99 | 406.02 | 398.44 | 386.58 | 403.46 | 387.74 |